Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc. demonstrated robust financial performance, highlighted by a 5.6% year-over-year increase in total revenue per Accountable Healthcare Services Client (AHSC) to $26,622, driven by client expansion across its solutions. Additionally, patient payment volumes reached $1.181 billion in the third quarter of FY26, representing a 9.3% year-over-year growth, which underscores the company's successful client engagement strategy. Furthermore, management raised its FY26 adjusted EBITDA guidance to a range of $99 million to $101 million, indicating a 172% year-over-year growth projection, while also anticipating an increase in the number of AHSCs to 4,515, showcasing continued operational expansion and financial strength.

Phreesia Inc.'s financial outlook appears unfavorable due to a decline in key metrics, including a sequential drop in the take rate from 2.8% to 2.7% and a reduction in projected subscription revenue per account from $55.7K to $51.8K for FY27, representing a 7% decrease. Management's guidance also indicates a slowdown in organic growth expectations, falling from 18% in FY25 to approximately 13% for FY26, primarily due to a focus on expanding within the existing customer base rather than attracting new clients. Additionally, the company ended 3Q26 with 4,520 provider clients, slightly below expectations and indicative of limited growth potential in the current economic landscape, further exacerbated by potential external factors such as another surge in COVID-19 cases affecting patient visit volumes.